Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquafosol sodium vs polyethylene glycol eye drops with meibomian gland massage for mucin-abnormal dry eye
ChiCTR2200066093Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Nov 2022
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of diquafosol and macrogol in dry eye syndrome (DED) (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Time to tear film rupture. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
diquafosolmacrogol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2200066093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066093.